Lakewood-Amedex Biotherapeutics Inc.
LABT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002079272
No open-market purchases or sales by Lakewood-Amedex Biotherapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $306.5K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Lakewood-Amedex Biotherapeutics Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 0 | 6 | +6 |
| Shares | 0 | 97.8K | +97.8K |
| Value | $0 | $306.5K | +$306.5K |
New holders (6)
Institutions that held Lakewood-Amedex Biotherapeutics Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marex Group plc | 48,167 | $151.2K | 0.00% |
| HRT Financial LP | 44,782 | $140.0K | 0.00% |
| UBS Group AG | 4,098 | $12.9K | 0.00% |
| Tower Research Capital LLC (TRC) | 624 | $1.96K | 0.00% |
| Advisor Group Holdings, Inc. | 138 | $433 | 0.00% |
| Ronald Blue Trust, Inc. | 11 | $35 | 0.00% |
Sold out (0)
Institutions that held Lakewood-Amedex Biotherapeutics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
None.